Skip to Content

Medibank Private Ltd

MPL: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
A$8.90JjqzwrZrmmtlw

Medibank's First-Half Profit Slumps on Higher Claims, FVE Reduced to AUD 3.10

Narrow-moat Medibank reported a weak first-half fiscal 2020 result, with a 9% fall in NPAT to AUD 179 million reflective of industry challenges. The core health insurance business performed worse than the headline implies, down 20%, with investment income of AUD 38.5 million a sharp recovery from a meagre AUD 4.1 million last year. We expect the tough operating environment to persist, but claims inflation should slow.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of MPL so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center